Xiaowei Qi

5.5k citations
184 papers · 4.4k · 1 hit paper · h-index 36

Impact in

    • Cancer-related molecular mechanisms research
    • Breast Cancer Treatment Studies
    • MicroRNA in disease regulation
  • Oncology top 5%
    • Cancer Cells and Metastasis

Papers in

    • Breast Cancer Treatment Studies 30
    • HER2/EGFR in Cancer Research 13
    • Colorectal Cancer Treatments and Studies 11
    • Cancer Immunotherapy and Biomarkers 10
    • Cancer Cells and Metastasis 7

Xiaowei Qi

181 papers receiving 4.3k citations

Xiaowei Qi's Hit Papers

Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis 2024 · 112 citations
1120+1Years since publication255075100

Peers

Xiaowei Qi
Comparison fields: 5 of 121
  • Cancer Research 1.1k
  • Oncology 716
  • Drug Discovery 9
  • Sensory Systems 91
  • Molecular Biology 1.1k
Replace Zhengzhi Zou with:
Zhengzhi Zou China
Chang Zou China
Jong In Yook South Korea
Francesca Bianchini Italy
Ya Zhang China
Ye Chen China
Kangsheng Tu China
Johanna Chiche France
Jaetae Lee South Korea
Minjie Wei China
Xiaowei Qi relative to Zhengzhi Zou China Zhengzhi Zou's profile →
Citations per field
00.5×1.5×2×2.3×
Zhengzhi Zou · 1×
Citations per year

Countries citing papers authored by Xiaowei Qi

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Qi more than expected).

Fields of papers citing papers by Xiaowei Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Qi. The network helps show where Xiaowei Qi may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaowei Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaowei Qi Line = papers co-authored together Xiaowei Qi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2016322
2 2014169
3
Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer.
2019119
4 2022116
5 2018114
6 2018114
7
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
Hit paper breakdown →
2024112
8 2017101
9 201497
10 201596
11 201492
12 201682
13 201881
14 201271
15 201461
16 202161
17
Multifaceted regulation and functions of replication factor C family in human cancers.
201858
18 201257
19 201255
20 201154

About Xiaowei Qi

Xiaowei Qi is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Biomaterials, having authored 184 papers that have together received 4.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (30 papers), HER2/EGFR in Cancer Research (13 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Cells and Metastasis (7 papers), Electrochemical sensors and biosensors (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (716 citations), Drug Discovery (9 citations), Sensory Systems (91 citations) and Molecular Biology (1.1k citations). Xiaowei Qi has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jun Jiang, Wei Sun, Yuan Yin, Hongwei Gao, Yi Zhang, Junlan Liu, Long Yuan, Yong Mao, Dong Hua and Linfang Jin. Their work appears in journals such as Frontiers in Oncology, Journal of Nanobiotechnology, Scientific Reports, The Oncologist and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact